Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee
Public ClinicalTrials.gov record NCT03046446. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Study to Assess the Safety of Repeat Administration of FX006 to Patients With Osteoarthritis of the Knee
Study identification
- NCT ID
- NCT03046446
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Industry
- Enrollment
- 208 participants
Conditions and interventions
Conditions
Interventions
- FX006 32 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 19, 2017
- Primary completion
- Jul 18, 2018
- Completion
- Jul 18, 2018
- Last update posted
- Jan 23, 2024
2017 – 2018
United States locations
- U.S. sites
- 17
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tucson Orthopedic | Tucson | Arizona | 85712 | — |
| Dream Team Clinical Research | Anaheim | California | 92801 | — |
| Hope Clinical Research | Canoga Park | California | 91303 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| Harbor-UCLA Medical Center | Torrance | California | 90509 | — |
| Tampa Bay Medical Research | Clearwater | Florida | 37761 | — |
| The Andrews Institute | Gulf Breeze | Florida | 32561 | — |
| Ochsner Sports Medicine Institute | New Orleans | Louisiana | 70121 | — |
| Brigham and Women's Hospital | Chestnut Hill | Massachusetts | 02467 | — |
| New England Baptist Hospital | Dedham | Massachusetts | 02026 | — |
| Rochester Clinical Research | Rochester | New York | 14609 | — |
| Duke University | Durham | North Carolina | 27701 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| PMG Research of Knoxville | Knoxville | Tennessee | 37938 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03046446, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 23, 2024 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03046446 live on ClinicalTrials.gov.